iPremom

Raised $17.4M in a Seed round, announced 2 September 2026.

Round

iPremom raised €15 million to clinically validate and commercially roll out its MaiRa early pregnancy-complications testing platform.

Amount
$17.4M
Stage
Seed
Announced
2 September 2026
Investors
Amadeus Capital Partners, Asabys Partners, APEX Ventures
Checked
Amount and date matched across 2 press sources

Company

Develops blood tests detecting pregnancy complications during the first trimester

Based in
Spain
Sector
Health
Website
ipremom.com ↗

Sources and links

Sources
Exclusive: Femtech Ipremom raises €15m seed for early detection of pregnancy complications sifted.eu
Adressing complicated pregnancies, iPremom raises €15 million to advance early detection eu-startups.com
Website
ipremom.com ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost